Liang, Menglin MD; Wu, Meiqi MD; Jia, Chenhao MD; Guo, Ruijie MD; Cui, Ruixue PhD, MD
From the Department of Nuclear Medicine, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College; and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Received for publication September 12, 2022; revision accepted November 16, 2022.
Conflicts of interest and sources of funding: This work was financially supported by the CAMS Innovation Fund for Medical Sciences (grant CAMS-2022-I2M-JB-001). The authors have no conflicts of interest to report.
M.L. and M.W. contributed equally to this work.
Correspondence to: Ruixue Cui, PhD, MD, Department of Nuclear Medicine, Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China. E-mail: [email protected].
